Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease
Lifan Zhang, Xiaolin Yu, Mei Ji, et al.
Food & Function (2018) Vol. 9, Iss. 12, pp. 6414-6426
Closed Access | Times Cited: 103

Showing 51-75 of 103 citing articles:

Natural Autophagy Activators to Fight Age-Related Diseases
Vianey M. Mundo Rivera, José Roberto Tlacuahuac Juárez, Nadia Mireya Murillo-Melo, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1611-1611
Open Access | Times Cited: 3
Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases
Biswajit Kumar Utpal, Fatima Zohra Mokhfi, Mehrukh Zehravi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective
Keng Yoon Yeong, Nurken Berdigaliyev, Yuin Chang
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 24, pp. 4073-4091
Closed Access | Times Cited: 27
Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation
Megha Jhanji, C.N.R. Rao, Mathew Sajish
GeroScience (2020) Vol. 43, Iss. 3, pp. 1171-1200
Open Access | Times Cited: 26
Tianma Gouteng granules decreases the susceptibility of Parkinson's disease by inhibiting ALOX15-mediated lipid peroxidation
Yingnan Jiang, Yongzhi Guo, Dan-Hua Lu, et al.
Journal of Ethnopharmacology (2020) Vol. 256, pp. 112824-112824
Closed Access | Times Cited: 24
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies
Samay Prakash, Wayne G. Carter
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1573-1573
Open Access | Times Cited: 23
How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review
Tracy D. Zhang, Scott Kolbe, Leah C. Beauchamp, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3026-3026
Open Access | Times Cited: 15
Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia
Gabriel F. Martins, Nuno Galamba
Critical Reviews in Biochemistry and Molecular Biology (2023) Vol. 58, Iss. 1, pp. 50-80
Open Access | Times Cited: 8
Silyl resveratrol derivatives as potential therapeutic agents for neurodegenerative and neurological diseases
Efres Belmonte‐Reche, Pablo Peñalver, Marta Caro, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113655-113655
Open Access | Times Cited: 20
Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
Rodrigo Pérez-Arancibia, Marisol Cisternas-Olmedo, Denisse Sepúlveda, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Protective Effects of Polydatin Against Dementia-Related Disorders
Kim San Tang
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 127-135
Open Access | Times Cited: 18
The Potential Effects of Red Wine and Its Components on Neurocognitive Disorders: A Narrative Review
Virginia Boccardi, Luca Tagliafico, A Persia, et al.
Nutrients (2024) Vol. 16, Iss. 20, pp. 3431-3431
Open Access | Times Cited: 2
Inhibitory Effects Induced by Vicia faba, Uncaria rhyncophylla, and Glycyrrhiza glabra Water Extracts on Oxidative Stress Biomarkers and Dopamine Turnover in HypoE22 Cells and Isolated Rat Striatum Challenged with 6-Hydroxydopamine
Giustino Orlando, Annalisa Chiavaroli, Sheila Leone, et al.
Antioxidants (2019) Vol. 8, Iss. 12, pp. 602-602
Open Access | Times Cited: 16
Impact of dietary polyphenols on neuroinflammation-associated disorders
Neeraja Revi, Aravind Kumar Rengan
Neurological Sciences (2021) Vol. 42, Iss. 8, pp. 3101-3119
Closed Access | Times Cited: 14
Ellagic acid rescues motor and cognitive deficits in the R6/2 mouse model of Huntington's disease by lowering mutant huntingtin protein
Xun Sun, Jie Zhu, Xiaoying Sun, et al.
Food & Function (2020) Vol. 11, Iss. 2, pp. 1334-1348
Closed Access | Times Cited: 13
7,8-Dihydroxyflavone ameliorates mitochondrial impairment and motor dysfunction in the α-synuclein 1–103 transgenic mice
Ye Tian, Lina Pan, Xin Yuan, et al.
Neurobiology of Disease (2022) Vol. 169, pp. 105736-105736
Open Access | Times Cited: 8
A Review on the Efficacy of Plant-derived Bio-active Compounds Curcumin and Aged Garlic Extract in Modulating Cancer and Age-related Diseases
Diptimayee Das, Murhekar Kanchan, Abhijit Mitra, et al.
Current Reviews in Clinical and Experimental Pharmacology (2023) Vol. 19, Iss. 2, pp. 146-162
Closed Access | Times Cited: 4
Gardenin A treatment attenuates inflammatory markers, synuclein pathology and deficits in tyrosine hydroxylase expression and improves cognitive and motor function in A53T-α-syn mice
Wyatt Hack, Noah Gladen-Kolarsky, Swarnali Chatterjee, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116370-116370
Open Access | Times Cited: 1
MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle
Jinbao Guo, Li Zhong, Mohammad Momeni
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases
Mengying Xu, Tianjiao Li, Xuan Liu, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Review of Pre-clinical Studies
Samay Prakash, Wayne G. Carter
(2021)
Open Access | Times Cited: 9
Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease
Ye Tian, Mingyang He, Lina Pan, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 9
Vaccines targeting the primary amino acid sequence and conformational epitope of amyloid‐β had distinct effects on neuropathology and cognitive deficits in EAE/AD mice
Xiaolin Yu, Jie Zhu, Xiang‐meng Liu, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 12, pp. 2860-2871
Open Access | Times Cited: 8
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Poornima D. E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong‐Sun Kim, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 560-577
Open Access | Times Cited: 5
A critical analysis on the concentrations of phenolic compounds tested using in vitro and in vivo Parkinson’s disease models
José Messias Perdigão, Bruno José Brito Teixeira, Vinicius Carvalho-da-Silva, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 19, pp. 6596-6615
Open Access | Times Cited: 2

Scroll to top